Evaluation of Efficacy and Safety of Zinobliss (Zinc Carnosine 2% and Lignocaine 2%) for the Management of Oral Mucositis and Stomatitis: A Phase 3 Prospective Randomized Open Label Multi Centric Parallel Design Study

Document Type : Original Article


1 Department of Medico Marketing of Ki3(CRO), University of Calcutta, West Bengal, India

2 Department of Oral & Maxillofacial Pathology and Oral Microbiology, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth University, Puducherry, India

3 Department of Pharmacology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India

4 Department of Human Resources & Marketing, Mumbai University, Puneet Laboratories, Mumbai ,India

5 Executive Director, Puneeth Laboratories, Mumbai University, Mumbai, India

6 Principal Investigator, KI3, CRO, Pondicherry, University, Chennai, Tamil Nadu, India


Background and aim: Oral mucositis occurs in almost 90% of Head and Neck cancer patients receiving radiotherapy.  Zinc L carnosine, the chelation of zinc with carnosine, is beneficial for oral mucosal ulcers due to its antioxidant properties.  It also causes increased mucous production, which helps repair the injury.  The pain in oral mucositis can be addressed with the help of a local anesthetic agent, lignocaine hydrochloride.  The objective was to study the efficacy of ZINOBLISS (Zinc Carnosine 2% and lignocaine HCl 2%) for managing oral mucositis and stomatitis.
Material and methods: It was an open-label, multicentric, parallel-group interventional clinical trial.  The total number of patients included in the study was 45 (each group was 15).  Arm 1 included topical administration of Zinobliss (Zinc Carnosine 2% and Lignocaine HCl 2% Gel) thrice daily for ten days or until healing, whichever was earlier.  Similarly, Arm 2 and Arm 3 included topical administration of Hexigel (Chlorhexidine Gluconate Gel) and Zytee- L (Gel containing Choline Salicylate, Lignocaine Hydrochloride, and Benzalkonium Chloride solution), respectively, thrice daily for ten days or until healing whichever was earlier.
Results: The accelerated healing response in subjects treated with Zinobliss by day 4, compared to Hexigel and Zytee L, took 7 to 10 days.  Zinobliss treatment did not necessitate any modifications to the subject's diet plans.
Conclusions: Zinobliss is a highly effective and well-tolerated treatment option for oral mucositis and stomatitis.


Main Subjects

[1] Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A, et al. Oral mucositis: the hidden side of cancer therapy. Journal of experimental & clinical cancer research. 2020;39:210. https://doi.org/10.1186/s13046-020-01715-7.
[2] Shetty SS, Maruthi M, Dhara V, de Arruda JA, Abreu LG, Mesquita RA, et al. Oral mucositis: Current knowledge and future directions. Disease-a-Month. 2022;68(5):101300. https://doi.org/10.1016/j.disamonth.2021.101300.
[3] Kitagawa J, Kobayashi R, Nagata Y, Kasahara S, Ono T, Sawada M, et al. Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial. International Journal of Cancer. 2021;148(6):1462-9. https://doi.org/10.1002/ijc.33316.
[4] Hewlings S, Kalman D. A review of zinc-L-carnosine and its positive effects on oral mucositis, taste disorders, and gastrointestinal disorders. Nutrients. 2020;12(3):665. https://doi.org/10.3390/nu12030665.
[5] Elad S, Yarom N, Zadik Y, Kuten‐Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA: a cancer journal for clinicians. 2022;72(1):57-77. https://doi.org/10.3322/caac.21704.
[6] Cesak O, Vostalova J, Vidlar A, Bastlova P, Student Jr V. Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment. Nutrients. 2023;15(7):1770. https://doi.org/10.3390/nu15071770.
[7] Tsubura-Okubo M, Komiyama Y, Kamimura R, Sawatani Y, Arai H, Mitani K, et al. Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients. International Journal of Oral and Maxillofacial Surgery. 2021;50(7):906-14. https://doi.org/10.1016/j.ijom.2020.10.004.
[8] Lee CT, Galloway TJ. Pathogenesis and amelioration of radiation-induced oral mucositis. Current Treatment Options in Oncology. 2022;23(3):311-24. https://doi.org/10.1007/s11864-022-00959-z.
[9] Ana GS, Normando AG, de Toledo IP, Dos Reis PE, Guerra EN. Topical treatment of oral mucositis in cancer patients: a systematic review of randomized clinical trials. Asian Pacific Journal of Cancer Prevention: APJCP. 2020;21(7):1851-66. https://doi.org/10.31557%2FAPJCP.2020.21.7.1851.
[10] Elad S, Cheng KK, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423-31. https://doi.org/10.1002/cncr.33100.
[11] Tang W, Liu H, Ooi TC, Rajab NF, Cao H, Sharif R. Zinc carnosine: Frontiers advances of supplement for cancer therapy. Biomedicine & Pharmacotherapy. 2022;151:113157. https://doi.org/10.1016/j.biopha.2022.113157.
[12] Efthymakis K, Neri M. The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clinics and Research in Hepatology and Gastroenterology. 2022;46(7):101954. https://doi.org/10.1016/j.clinre.2022.101954.
[13] Mohammadi F, Oshvandi K, Kamallan SR, Khazaei S, Ranjbar H, Ahmadi‐Motamayel F, et al. Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy. Nursing Open. 2022;9(3):1602-11. https://doi.org/10.1002/nop2.1168.
[14] Mehdipour M, Zenoz AT, Kermani IA, Hosseinpour A. A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2011;19(1):71-3.
[15]  Mosalaei A, Nasrolahi H, Shafizad A, Ahmadloo N, Ansari M, Shirazi MA, et al. Effect of Oral Zinc Sulphate in Prevention of Radiation Induced Oropharyngeal Mucositis During and After Radiotherapy in Patients with Head and Neck Cancers. Middle East Journal of Cancer 2010;1(2): 69-76.